Alethio Therapeutics Raises $90 Million in Series A Financing
The oversubscribed financing was co-led by Sofinnova Partners and RA Capital, alongside founding investor Oxford Sc.
Related stories
Siemens Energy Shares Hit 46-week Low
Siemens Energy shares decreased to 116.82 EUR, the lowest since December 2025. Over the past 4 weeks, Siemens Energy AG lost 18.98%, and in the last 12 months, it increased 14.21%.
L impact | EQUITY | Nov 05, 2026, 08:09 AM UTC
Photocat Reaffirms 2026 Revenue and EBITDA Guidance
Photocat reaffirmed full-year 2026 net revenue guidance of DKK 13.0 million to DKK 15.0 million and EBITDA guidance of DKK 0.5 million to DKK 1.5 million. It also completed the lau
M impact | EQUITY | Nov 05, 2026, 08:05 AM UTC
SciVision Biotech Reports Third-Quarter Net Profit of NT$23.0 Million
SciVision Biotech reported third-quarter net profit of NT$23.0 million, compared with NT$58.3 million a year earlier. Revenue was NT$202.671 million versus NT$221.410 million.
M impact | EQUITY | Nov 05, 2026, 08:04 AM UTC
Truworths Group Retail Sales Fall 4.3% in First 17 Weeks of FY2027
M impact | EQUITY | Nov 05, 2026, 08:03 AM UTC
Shares In Rheinmetall Ag Down 12.5% After Results
L impact | EQUITY | Nov 05, 2026, 08:03 AM UTC
ArcelorMittal Shares Rise 5.8% in Amsterdam After Results
M impact | EQUITY | Nov 05, 2026, 08:03 AM UTC